Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Debt Ratio: 2020-2025

Historic Debt Ratio for Insight Molecular Diagnostics (IMDX) over the last 5 years, with Sep 2025 value amounting to 0.02.

  • Insight Molecular Diagnostics' Debt Ratio rose 174.85% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year increase of 174.85%. This contributed to the annual value of 0.01 for FY2024, which is 78.97% down from last year.
  • Insight Molecular Diagnostics' Debt Ratio amounted to 0.02 in Q3 2025, which was up 76.22% from 0.01 recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Debt Ratio peaked at 0.07 during Q2 2021, and registered a low of 0.00 during Q3 2022.
  • Moreover, its 3-year median value for Debt Ratio was 0.01 (2024), whereas its average is 0.01.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Debt Ratio crashed by 95.17% in 2022 and then soared by 2,737.24% in 2023.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Debt Ratio stood at 0.01 in 2021, then tumbled by 87.48% to 0.00 in 2022, then surged by 2,737.24% to 0.03 in 2023, then crashed by 78.97% to 0.01 in 2024, then soared by 174.85% to 0.02 in 2025.
  • Its Debt Ratio stands at 0.02 for Q3 2025, versus 0.01 for Q2 2025 and 0.01 for Q1 2025.